The Union Cycliste Internationale (UCI) announces that Portuguese rider André Cardoso was notified of an Adverse Analytical Finding (AAF) of Erythropoietin in a sample collected in the scope of an out-of-competition control on 18 June 2017.
The control was planned and carried out by the Cycling Anti-Doping Foundation (CADF), the independent body mandated by the UCI, in charge of defining and implementing the anti-doping strategy in cycling.
The rider has the right to request and attend the analysis of the B sample. In accordance with UCI Anti-Doping Rules, the rider has been provisionally suspended until the adjudication of the affair.
At this stage of the procedure, the UCI will not comment any further on any of these matters.
For more information, please contact:
Louis Chenaille
UCI Press Officer
Tel: +41 79 198 7047
Email: louis.chenaille@uci.ch
John Zerafa
VERO Communications
Tel: +44 7813 814 816
Email: jzerafa@verocom.co.uk
25 Years at #1: Your best source of news about the Olympics iswww.aroundtherings.com, for subscribers onlyÚltimas Noticias
Sinner-Alcaraz, the duel that came to succeed the three phenomenons
Table tennis: Brazil’s Bruna Costa Alexandre will be Olympic and Paralympic in Paris 2024
Rugby 7s: the best player of 2023 would only play the medal match in Paris
Rhonex Kipruto, owner of the world record for the 10000 meters on the road, was suspended for six years
Katie Ledecky spoke about doping Chinese swimmers: “It’s difficult to go to Paris knowing that we’re going to compete with some of these athletes”
